Accordingly, exosomal ZIP4 from the serum of PaCa patients can be used as a diagnostic marker for cancer progression [145]. Here, SLC39A4 is linked to permanent neonatal diabetes mellitus-pancreatic and cerebellar agenesis syndrome.